Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

Company Events - Lisata Therapeutics will participate in several upcoming events in November 2024, including BIO-Europe, PEGS Europe Summit, and LSX Inv€$tival showcase [1][2][3] - At BIO-Europe, Tariq Imam, Vice President of Business Development and Operations, will engage in one-on-one meetings [1] - David J. Mazzo, PhD, President and CEO, will present at PEGS Europe on November 5, 2024, at 3:20 p.m. CEST [2] - David J. Mazzo will also present at the LSX Inv€$tival showcase on November 18, 2024, at 1:00 p.m. GMT [3] Company Overview - Lisata Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative therapies for advanced solid tumors and other serious diseases [4] - The company's investigational drug, certepetide, utilizes a novel uptake pathway to enhance the targeting and penetration of anti-cancer drugs in solid tumors [4] - Lisata has established significant commercial and R&D partnerships based on its CendR Platform® technology and anticipates announcing multiple milestones over the next 1.5 years [4] - The company projects that its capital will support operations into early 2026, covering expected data milestones from ongoing and planned clinical trials [4]